41 result(s) for 'Validation'
1 - 10 of 41 results for 'Validation'
Sort by
Show
Join Dr. Bethany Williams as she shares practical advice on how we can utilize Digital Pathology to report from home safely and confidently.
BOND ancillaries have been designed for Leica Biosystems fully-automated BOND systems: BOND-MAX and BOND-III systems. Used in the development and validation of BOND ready-to-use primary
antibodies and ISH probes - choose Leica Biosystems reagents for the assurance of a quality result in your laboratory. The Stringency Wash Solution is intended for use with biotin tagged DNA probes to reduce
non-specific DNA hybridization in formalin-fixed, paraff...
In surgical pathology more than ever, the laboratories are expected to do more with less. Taking on more specimens with less technical staff, or getting more stains out of tiny biopsies or fine needle aspirations have become the norm. The College of American...
BOND ancillaries have been designed for Leica Biosystems fully-automated BOND systems: BOND-MAX and BOND-III systems. Used in the development and validation of BOND ready-to-use primary antibodies and ISH probes - choose Leica Biosystems reagents for the assurance of a quality result in your laboratory.
DNA ISH allows the detection and visualization of specific DNA sequences in tissue sections.
Anti-Biotin Antibody is intended for use with biotin...
by Chad Salinas, Vice President, AI and Machine Learning
Artificial Intelligence is exponentially increasing its impact on healthcare. As deep learning is mastering computer vision tasks, its application to digital pathology is natural, with the promise of aiding in routine reporting and standardizing results across trials. 1
Physicians recognize the potential of AI in pathology, with one global survey documenting nearly 75% of respondents reporting interest or excitement in AI as a diagnostic tool to facilitate improvements in workflow efficiency and quality assurance in pathology.2 This finding is, in part, a recognition of the increasing complexity associated with practicing pathology: complicated workflows3 coupled with global pathology workforce shortages4,5 impact patholo...
Different types of cancers frequently metastase to bone tissue. Treatment planning decisions are often based upon histology and special staining of these distant sites of disease. These decisions may rely on the outcome of immunohistochemistry, in situ...
The Power of Digital Pathology in Research
1. Leica Biosystems Proprietary Information. For Research Use Only. Not For Use in Diagnostic The Power of Digital Pathology In Research. Caitríona Lyons PhD.
2. Introduction • Caitríona Lyons PhD • Based in Dublin, Ireland • Current Role: • Product Manager Image Analysis, Leica Biosystems • Previous Roles: • Product Owner Image Analysis, Leica Biosystems • Image Analysis Specialist, Leica Biosystems • Education • BSc (Hons) Biomedical Science • PhD Medicine and Health • Postdoc Immunology
3. Agenda • History of Pathology • What is Digital Pathology • Power of Digital Pathology • Leica Biosystems Role in Digital Pathology • The Future of Digital Pathology • Final Thoughts 3 SCAN MANAGE ANALYZE
4. History of Digital Pathology • Patholog...